Reproxalap was found to be safe to take in patients diagnosed with dry eye disease (DED), as no serious treatment-emergent adverse events (TEAEs) were reported in patients taking the medication. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results